KORU Medical Systems (NASDAQ:KRMD) Rating Increased to Strong-Buy at Wall Street Zen

KORU Medical Systems (NASDAQ:KRMD) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday.

KRMD has been the subject of several other research reports. Lake Street Capital increased their price target on KORU Medical Systems from $6.00 to $8.00 and gave the stock a “buy” rating in a research note on Monday. Weiss Ratings restated a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Wednesday, October 8th. Finally, Canaccord Genuity Group upped their price objective on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $5.88.

KORU Medical Systems Stock Performance

Shares of KRMD stock opened at $6.23 on Friday. KORU Medical Systems has a 12-month low of $1.86 and a 12-month high of $6.61. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.48 and a quick ratio of 1.92. The firm has a market capitalization of $288.57 million, a price-to-earnings ratio of -77.88 and a beta of 0.58. The business has a 50 day simple moving average of $4.97 and a 200 day simple moving average of $4.19.

Hedge Funds Weigh In On KORU Medical Systems

Several hedge funds have recently modified their holdings of the company. Police & Firemen s Retirement System of New Jersey acquired a new stake in shares of KORU Medical Systems in the second quarter valued at $30,000. BNP Paribas Financial Markets grew its holdings in KORU Medical Systems by 52.1% during the third quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock worth $39,000 after acquiring an additional 3,478 shares during the period. Lazard Asset Management LLC bought a new stake in KORU Medical Systems in the second quarter worth about $59,000. Acadian Asset Management LLC bought a new stake in KORU Medical Systems in the first quarter worth about $63,000. Finally, Intech Investment Management LLC acquired a new stake in KORU Medical Systems in the 2nd quarter valued at about $73,000. 58.60% of the stock is currently owned by institutional investors and hedge funds.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.